Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Stroke & Vascular Topic Center

News
Allogeneic stem cell therapy for ischemic stroke is safe, but is it effective?
02/13/2024
Jolynn Tumolo
Intravenous allogeneic stem cell therapy within 18 to 36 hours of ischemic stroke onset was safe but did not improve short-term outcomes compared with placebo, according to study results from a phase 2/3 trial published in JAMA Neurology.
Intravenous allogeneic stem cell therapy within 18 to 36 hours of ischemic stroke onset was safe but did not improve short-term outcomes compared with placebo, according to study results from a phase 2/3 trial published in JAMA Neurology.
Intravenous allogeneic stem cell...
02/13/2024
Neurology
News
Viz.ai Announces Six Clinical Studies that Further Validate Impact of Viz™ Neuro Suite on Patient Care
02/07/2024

Viz.ai Press Release

Viz.ai Press Release
Real-world evidence presented at the 2024 International Stroke Conference shows positive impact on clinical workflow and patient benefits of AI-powered care coordination
Real-world evidence presented at the 2024 International Stroke Conference shows positive impact on clinical workflow and patient benefits of AI-powered care coordination
Real-world evidence presented at...
02/07/2024
EP Lab Digest
Stroke & Heart Attack
AHA: Stroke or Stroke Plus Carotid or Vertebral Artery Dissection Almost Doubled Risk of Heart Attack Within One Year
02/01/2024

American Heart Association News

American Heart Association News ...
Heart attack risk almost doubles in the first year after a stroke or when combined with a tear in a neck artery wall; however, a tear without a stroke does not seem to raise heart attack risk, according to preliminary research.
Heart attack risk almost doubles in the first year after a stroke or when combined with a tear in a neck artery wall; however, a tear without a stroke does not seem to raise heart attack risk, according to preliminary research.
Heart attack risk almost doubles...
02/01/2024
Cath Lab Digest
News
AF Risk Increases Over Time in Patients With Stroke Attributed to LAD, SVD
11/14/2023
Jolynn Tumolo
Atrial fibrillation detection rose from 12.5% at 1 year to 21.7% in 3 years in patients with stroke attributed to large-artery atherosclerotic disease and small-vessel occlusive disease who were monitored with an insertable cardiac monitor.
Atrial fibrillation detection rose from 12.5% at 1 year to 21.7% in 3 years in patients with stroke attributed to large-artery atherosclerotic disease and small-vessel occlusive disease who were monitored with an insertable cardiac monitor.
Atrial fibrillation detection...
11/14/2023
Neurology
No Evidence Stroke, Hypertension Mediates Link Between Air Pollution and Dementia
News
No Evidence Stroke, Hypertension Mediates Link Between Air Pollution and Dementia
10/23/2023
Jolynn Tumolo
Hypertension and stroke do not mediate or modify the association between exposure to fine particulate matter air pollution (PM2.5) with incident dementia, according to study results published online in JAMA Network Open. “Although we...
Hypertension and stroke do not mediate or modify the association between exposure to fine particulate matter air pollution (PM2.5) with incident dementia, according to study results published online in JAMA Network Open. “Although we...
Hypertension and stroke do not...
10/23/2023
Neurology
News
Deep Brain Stimulation May Help Stroke Patients Recover From Motor Impairment
08/25/2023
Brionna Mendoza
A first-in-humans trial undertaken by Cleveland Clinic researchers has shown that using deep brain stimulation (DBS) to target the dentate nucleus of the cerebellum may help post-stroke rehabilitation patients recover from motor impairment.
A first-in-humans trial undertaken by Cleveland Clinic researchers has shown that using deep brain stimulation (DBS) to target the dentate nucleus of the cerebellum may help post-stroke rehabilitation patients recover from motor impairment.
A first-in-humans trial...
08/25/2023
Neurology
News
High Post-Stroke Glucose Levels Linked With Faster Cognitive Decline
07/12/2023
Evi Arthur
High post-stroke glucose levels were associated with faster cognitive decline in a recent meta-analysis published in JAMA Network Open. “These findings suggest that higher cumulative glucose levels may contribute to faster cognitive...
High post-stroke glucose levels were associated with faster cognitive decline in a recent meta-analysis published in JAMA Network Open. “These findings suggest that higher cumulative glucose levels may contribute to faster cognitive...
High post-stroke glucose levels...
07/12/2023
Neurology
A woman neurologist talks to a man patient using a brain model to demonstrate points
News
Merits of Early Blood Pressure Control for ICH Stroke Confirmed by INTERACT3 Trial Findings
06/28/2023
Brionna Mendoza
A swift reduction of systolic blood pressure significantly increases the chances of survival without significant impairment in intracerebral hemorrhage (ICH) stroke patients.
A swift reduction of systolic blood pressure significantly increases the chances of survival without significant impairment in intracerebral hemorrhage (ICH) stroke patients.
A swift reduction of systolic...
06/28/2023
Neurology
Four people ponder with question marks over their heads
Quiz
How many global stroke deaths will there be by 2030?
06/20/2023
Test your neurology knowledge with this quick quiz!
Test your neurology knowledge with this quick quiz!
Test your neurology knowledge...
06/20/2023
Neurology
Hyperglycemia After Stroke Associated With Faster Cognitive Decline
News
Hyperglycemia After Stroke Associated With Faster Cognitive Decline
06/15/2023
Jolynn Tumolo
Higher blood glucose in stroke survivors was associated with faster decline in global cognition, according to a study published online in JAMA Network Open. 
Higher blood glucose in stroke survivors was associated with faster decline in global cognition, according to a study published online in JAMA Network Open. 
Higher blood glucose in stroke...
06/15/2023
Neurology

Advertisement

Advertisement

News

brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
A brain puzzle against an orange background
News
Prestroke Antiplatelet Therapy Linked With Symptomatic Intracerebral Hemorrhage After Thrombolysis
06/10/2024
Jolynn Tumolo
Prestroke single and dual antiplatelet therapy are associated with an increased risk of symptomatic intracerebral hemorrhage after treatment with intravenous alteplase for acute ischemic stroke.
Prestroke single and dual antiplatelet therapy are associated with an increased risk of symptomatic intracerebral hemorrhage after treatment with intravenous alteplase for acute ischemic stroke.
Prestroke single and dual...
06/10/2024
Neurology
Tirofiban After Acute Ischemic Stroke Eases Early Neurological Deterioration
News
Tirofiban After Acute Ischemic Stroke Eases Early Neurological Deterioration
06/04/2024
Jolynn Tumolo
Intravenous tirofiban decreased the risk of early neurological deterioration in patients with acute noncardioembolic stroke without an increased risk of symptomatic intracerebral hemorrhage or systematic bleeding, according to study results...
Intravenous tirofiban decreased the risk of early neurological deterioration in patients with acute noncardioembolic stroke without an increased risk of symptomatic intracerebral hemorrhage or systematic bleeding, according to study results...
Intravenous tirofiban decreased...
06/04/2024
Neurology
No Significant Difference Between Anticoagulants, Antiplatelets in Preventing Events After Cervical Artery Dissection
News
No Significant Difference Between Anticoagulants, Antiplatelets in Preventing Events After Cervical Artery Dissection
06/03/2024
Jolynn Tumolo
Anticoagulation therapy in patients with cervical artery dissection was associated with a lower combined rate of 90-day ischemic stroke, major bleeding, or death compared with antiplatelet therapy, according to results published in JAMA...
Anticoagulation therapy in patients with cervical artery dissection was associated with a lower combined rate of 90-day ischemic stroke, major bleeding, or death compared with antiplatelet therapy, according to results published in JAMA...
Anticoagulation therapy in...
06/03/2024
Neurology
profile of head with heart over brain region
News
Any Level of Leisure-Time Physical Activity Aids in Stroke Prevention
04/25/2024
Jolynn Tumolo
Any amount of leisure-time physical activity helps to lower the risk of stroke compared with inactivity, according to a systematic review and meta-analysis published in the Journal of Neurology, Neurosurgery & Psychiatry.
Any amount of leisure-time physical activity helps to lower the risk of stroke compared with inactivity, according to a systematic review and meta-analysis published in the Journal of Neurology, Neurosurgery & Psychiatry.
Any amount of leisure-time...
04/25/2024
Neurology
a depiction of a cross section of a brain and spinal cord
News
Study Finds No Elevated Stroke Risk Days After COVID-19 Vaccination
04/12/2024
Jolynn Tumolo
COVID-19 vaccination does not appear to be associated with an increased risk of stroke in US older adults in the early days following administration, according to a study published in JAMA.
COVID-19 vaccination does not appear to be associated with an increased risk of stroke in US older adults in the early days following administration, according to a study published in JAMA.
COVID-19 vaccination does not...
04/12/2024
Neurology
Brain health
News
Hotter Outdoor Temps Raise Acute Ischemic Stroke Risk for Up to 10 Hours
03/18/2024
Jolynn Tumolo
Exposure to high temperatures was associated with an increased risk of acute ischemic stroke (AIS) onset at an hourly level, according to results from national case-crossover study in China published in JAMA Network Open.
Exposure to high temperatures was associated with an increased risk of acute ischemic stroke (AIS) onset at an hourly level, according to results from national case-crossover study in China published in JAMA Network Open.
Exposure to high temperatures...
03/18/2024
Neurology
Early venous filling
Stroke Research
Arterial Connections Improve Treatment Outcomes Following Stroke
02/26/2024

University of Zurich News

University of Zurich News
Researchers have demonstrated that the outcome of stroke treatments depends on the collateral network. Collaterals are blood vessels that cross-connect adjacent arterial trees, providing potential detour networks in case of a vascular...
Researchers have demonstrated that the outcome of stroke treatments depends on the collateral network. Collaterals are blood vessels that cross-connect adjacent arterial trees, providing potential detour networks in case of a vascular...
Researchers have demonstrated...
02/26/2024
Cath Lab Digest
News
Allogeneic stem cell therapy for ischemic stroke is safe, but is it effective?
02/13/2024
Jolynn Tumolo
Intravenous allogeneic stem cell therapy within 18 to 36 hours of ischemic stroke onset was safe but did not improve short-term outcomes compared with placebo, according to study results from a phase 2/3 trial published in JAMA Neurology.
Intravenous allogeneic stem cell therapy within 18 to 36 hours of ischemic stroke onset was safe but did not improve short-term outcomes compared with placebo, according to study results from a phase 2/3 trial published in JAMA Neurology.
Intravenous allogeneic stem cell...
02/13/2024
Neurology
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement